Deep Stock Research
XVI

Seven legendary value investors convened to evaluate CPRT (CPRT) through their individual lenses.

Warren Buffett Begin accumulating shares below $30 in measured increments, targeting a 3-4% portfolio position over 6-12 months as insurance volume data provides confirmation of cyclical trough.
I can predict with high confidence what this business looks like in 2035 — and that is the single most important criterion in my framework. The salvage vehicle auction industry is a duopoly where the dominant operator wins by putting more money into insurance carriers' pockets through superior buyer liquidity and faster cycle times. This is not a business that requires a genius to run it; it requires a platform that no one can replicate, and Copart has spent two decades and billions of dollars building exactly that. The buyer liquidity flywheel — more bidders drive higher prices, which attract more sellers, which attract more bidders — operates with the same self-reinforcing logic as Visa's payment network. The 9% ASP growth excluding catastrophe effects, achieved while industry vehicle values were flat, tells me the competitive advantage is widening, not stable.</p><p>The insurance volume headwind is real but emphatically cyclical. I have seen this pattern before — consumers pull back on coverage when premiums spike, carriers eventually compete for growth, coverage normalizes. What matters is that Copart's competitive position relative to IAA strengthens during downturns because the buyer liquidity advantage becomes more pronounced when fewer vehicles are available. This business demonstrated extraordinary resilience during the 2020 pandemic — revenue declined only 8% during the worst GDP contraction in modern history, and margins actually expanded. That is the financial proof of a genuine moat.</p><p>At $33.39, the stock is approximately fairly valued — which means I would not initiate a full position today but would begin accumulating below $28-30 where a genuine margin of safety emerges. The capital allocation history concerns me — five years of cash hoarding while shares diluted is not what I would have done — but the recent buyback initiation suggests the new management team recognizes the error. I would monitor buyback pace quarterly as the key behavioral indicator of whether management truly thinks like owners.

Key Points

  • Copart operates a simple, understandable business within a structural duopoly that I find very attractive. When an insurance company totals a vehicle, the salvage must be auctioned — and the realistic choices are Copart or IAA. This is not unlike a toll bridge: the activity cannot economically occur without paying one of two operators. With approximately 60% US market share and a buyer network spanning 190+ countries, Copart's competitive position is deeply entrenched and self-reinforcing.
  • The current unit volume decline of -8% and revenue contraction of -3.6% concern me not because they threaten the franchise, but because they create uncertainty around the timing of normalization. Management attributes the softness to consumer pullback on collision coverage and softer claims activity — forces I agree are more cyclical than secular. However, I have no ability to predict when insurance volumes will inflect, and I want to be compensated for that uncertainty with a meaningful discount to intrinsic value.
  • Capital allocation is adequate but I would like to see management demonstrate sustained net share reduction. The share count increased from 933 million in FY20 to 961 million by FY24, suggesting stock-based compensation has historically outpaced buybacks. The recent $500M buyback commitment is encouraging, but until net dilution reverses convincingly, I will not credit significant per-share accretion in my valuation. The $2B+ cash position provides excellent downside protection and strategic flexibility.

Pushback & Concerns

  • I respectfully disagree with David Tepper's urgency to buy at current prices. While the 2:1 risk/reward arithmetic is seductive, it assumes a volume recovery within his typical 12-18 month catalyst window. Insurance behavioral shifts — consumers dropping collision coverage — can persist for multiple years, particularly if cost-of-living pressures remain elevated. I prefer to let time and price align rather than front-run a catalyst with uncertain timing.
Charlie Munger Set limit orders at $29 and be patient. This business has given patient investors multiple opportunities to buy at attractive prices over the past decade, and current conditions suggest another entry point below $30 is plausible within 6-12 months if volume headwinds persist.
I invert every thesis. How do I lose money on Copart? The business itself cannot be destroyed — the physical infrastructure, buyer network, and insurance carrier relationships are permanent. A competitor cannot breach the moat because the cold-start problem (no buyers without inventory, no inventory without buyers) is unsolvable with capital alone. The only paths to permanent loss are: (1) management destroys value through a massive, debt-funded acquisition (low probability given the founder family's continued involvement), or (2) autonomous driving eliminates vehicle accidents within my holding period (extremely low probability within 10-15 years). When inversion produces only implausible paths to permanent loss, you are looking at an exceptional business.</p><p>The capital allocation history is the one legitimate concern. Sitting on $5 billion while shares diluted 3.6% over five years is precisely the kind of stupidity I would have corrected as a board member. The recent buyback initiation is welcome but unproven — I need to see sustained, aggressive repurchase activity over four to six quarters before I credit management with having learned the lesson. The insurance volume decline is noise in the context of a 20-year holding period.</p><p>At $33.39, this is not mispriced enough for me. I need to see $26-28 to commit capital — that provides the margin of safety where even if my normalized earnings estimate is wrong by 15%, I still make money over a decade. Patience is free; mistakes are expensive.

Key Points

  • Inverting the question — 'What could kill Copart?' — reveals a business with exceptional durability. Insurance companies cannot economically build in-house auction platforms (they lack the buyer network, land infrastructure, and technology). New entrants face massive barriers: Copart owns its land rather than leasing, has spent decades building a global buyer base, and benefits from powerful network effects where more buyers attract more sellers. The duopoly structure has been stable for over two decades, which tells me something important about the competitive dynamics.
  • Management quality passes my integrity test but not my capital allocation excellence test — yet. The decision to own rather than lease land is shrewd and creates a durable competitive advantage. However, the rising share count (933M to 961M over four years) while simultaneously running buyback programs reveals that management is, to some extent, running in place on per-share value creation. I want to see the announced buyback acceleration produce genuine net share reduction over the next 4-6 quarters before giving full credit.
  • The insurance volume cyclicality is a feature, not a bug — it creates periodic opportunities to buy a wonderful business at a merely good price. Current conditions (units -8%, revenue -3.6%) represent exactly this type of opportunity, but I insist on adequate compensation. At $33.39, the stock offers perhaps 8-10% upside to fair value, which is insufficient margin of safety for a business in a cyclical trough with uncertain recovery timing.

Pushback & Concerns

  • I push back on Mohnish Pabrai's characterization of the land portfolio as providing a meaningful 'asset floor.' While Copart's owned real estate is valuable, salvage yard land in suburban/exurban locations is a specialized asset class with limited alternative uses and potentially significant environmental liabilities. The operating franchise value — not the land — is what protects the downside, and that franchise is temporarily impaired by volume headwinds.
Dev Kantesaria Begin accumulating below $31, targeting a 2-3% portfolio weighting initially. Increase to 4-5% if management demonstrates net share reduction for three consecutive quarters while maintaining FCF margins above 25%.
Copart passes my toll-booth inevitability test with distinction. Can the underlying activity — the disposition of totaled vehicles — occur WITHOUT paying Copart's toll? Functionally, no. Insurance carriers must route their total-loss inventory through either Copart or IAA, and Copart's buyer liquidity advantage generates measurably higher returns. This is not a choice — it is a mandatory checkpoint on an essential economic activity, identical in structure to the credit ratings that must accompany every bond issuance (Moody's) or the credit scores that must accompany every mortgage application (FICO). The toll is embedded in the transaction, and the volume of underlying activity — vehicle accidents resulting in total losses — is driven by physics (vehicle complexity) rather than economic cycles. This is a structural monopoly in everything but name.</p><p>What excites me most is the GOAT Moat classification in Vinall's hierarchy: Copart wins by putting money into its customers' pockets. Every dollar of superior auction recovery reduces the insurance carrier's net loss cost. This is the highest-quality moat source because it creates perfect alignment between platform growth and customer value — the company grows BECAUSE it serves customers better, not despite them. The 9% ASP growth excluding catastrophe effects while industry vehicle values normalized is the clearest evidence I have seen of a buyer liquidity network effect operating independently of market conditions. This is comparable to Visa's payment network compounding — each additional buyer makes the platform more valuable for every seller.</p><p>At $33.39, Copart trades at approximately 26x trailing FCF — which is within my range for this quality but not at the discount I prefer for initial positions. I would begin accumulating at $30-32 and size it as a core holding at $28 or below. The capital allocation improvement — buyback initiation after years of hoarding — is a genuine positive inflection that could compound per-share value at 12-15% for the next decade. There is never a bad time to buy a compounder, but there are better times, and I am patient enough to wait for them.

Key Points

  • [Philosophy Guardrail] This is a commodity/cyclical business that fails my toll booth inevitability test. Alternative suppliers exist — customers can source from dozens of global competitors. I categorically exclude commodity cyclicals regardless of balance sheet strength or cycle timing.
  • Copart passes my toll booth test with high marks. When an insurance company declares a vehicle a total loss — a mandatory, non-discretionary event driven by actuarial math — the salvage must flow through an auction platform. The critical question is: can this activity occur without paying Copart's toll? The answer is 'only by paying IAA's toll instead,' which means the economic activity is trapped within a two-player system. This is structurally similar to Visa/Mastercard in payments — the customers have a choice of two, but they must choose one. I find this level of inevitability compelling.
  • My concern centers on capital allocation discipline, particularly the FCF-after-SBC metric I prioritize. With TTM FCF of ~$962M but stock-based compensation running at levels that produced net dilution of approximately 28 million shares over four years (933M to 961M), the true owner FCF is lower than the headline suggests. Management must demonstrate that buybacks are producing genuine per-share compounding, not merely offsetting employee compensation. I want to see FCF after SBC growing at 8%+ before assigning a full compounding machine premium.
  • The current valuation is reasonable but not compelling for a new position. At 2.96% FCF yield versus a 4.3% risk-free rate, I need to believe in sustained double-digit FCF growth to justify the current price — and that growth is temporarily challenged by the insurance volume cycle. I would prefer to initiate at a price where the starting FCF yield is closer to 3.5%, which implies approximately $31 per share on current FCF, giving me a comfortable margin while the volume cycle works itself out.

Pushback & Concerns

  • I disagree with David Tepper's catalyst-driven framing. My framework does not depend on correctly timing cyclical inflections — I invest in structural inevitability and let the compounding do the work. If the volume recovery takes 24 months instead of 12, Tepper's asymmetric trade becomes much less compelling, whereas my approach simply requires buying at a price where the starting yield provides adequate return even without a near-term catalyst.
David Tepper Initiate a 3-4% position at current prices ($33-34). Add up to 6% total if shares trade below $30 on continued volume weakness, which would represent a genuinely compelling entry point.
The setup is intriguing but not actionable at $33.39. I see a wide-moat business experiencing a cyclical volume trough — exactly the kind of situation where forced selling and sentiment capitulation can create asymmetric entries. The stock has already declined 45% from its $58.8B market cap peak in Q3 FY2025, which tells me growth investors have been exiting. But value investors haven't stepped in aggressively because the stock doesn't screen as traditionally cheap at 21x trailing earnings. This gap between seller exhaustion and buyer arrival is where I usually find my entries — but I need the price to drop another 25-30% to create the 3:1 asymmetry I demand.</p><p>The reflexivity dynamics are favorable: this is a REFLECTING situation, not a CAUSING one. The stock price decline does not worsen Copart's business fundamentals — insurance volumes are determined by consumer behavior and carrier pricing, not by the stock price. When volumes eventually recover, the stock will re-rate. The question is timing, and I do not have a catalyst that says 'volumes recover in Q3 FY2026' with high probability. I would rather wait for the next quarter of volume data and reassess.</p><p>If the stock reaches $24-26 — which would require another meaningful leg down, perhaps triggered by a worse-than-expected Q3 report or broader market weakness — I would build a significant tactical position with 12-18 month horizon targeting $36-40 on volume recovery. That is a 50-65% return with limited downside risk given the business quality. At $33.39, I deploy capital elsewhere.

Key Points

  • This is a textbook asymmetric setup in a franchise business. Copart trades at 23x TTM earnings — well below its 10-year average of 30-35x — because the market is extrapolating a temporary insurance volume decline into the valuation. The -8% unit decline and -3.6% revenue contraction are real, but they stem from consumer decisions about insurance coverage that are historically cyclical, not structural shifts in the salvage auction business model. When fear creates a discount in a duopoly, I pay attention.
  • The catalyst path is clear even if the timing is uncertain. Insurance carriers are completing multi-year rate increase cycles. As rates stabilize and competition for policies resumes, carriers will lower deductibles and consumers will restore collision coverage — the economics of going uninsured or underinsured on a depreciating asset only work for so long. Miles driven data remains robust. The used vehicle market remains active. The structural demand for salvage auctions is intact; what's compressed is the flow-through of insured total-loss claims.
  • The balance sheet makes this a low-risk bet. Approximately $2 billion in net cash on a $32B market cap means the equity is partially de-risked by financial assets. Even in a bear case where volumes decline another 5-10% from here, Copart generates enough free cash flow (~$800M+) to cover all operations and continue buying back stock. The floor is well-established, and I'm getting paid to wait for recovery through buyback accretion and cash accumulation.

Pushback & Concerns

  • I challenge Warren Buffett and Charlie Munger's insistence on waiting for $29-30. In my experience, by the time insurance volume data confirms a trough, the stock is already 15-20% higher. These tightly held duopolies re-rate quickly on the first positive data point. The opportunity cost of sitting on the sidelines — missing the initial 15-20% move while waiting for confirmation — is real and underappreciated by value investors who focus exclusively on entry price rather than expected value.
Robert Vinall Accumulate below $30, building toward a 4-5% portfolio position over 6-12 months. Focus on the capex normalization timeline as the key variable — when annual land acquisition spending moderates, FCF conversion should improve materially.
Copart earns the highest moat classification in my framework — the GOAT Moat — because it wins by saving its customers money. This is the most durable form of competitive advantage because the company's growth and customer value are perfectly aligned. Every dollar of superior auction recovery that Copart generates reduces the insurance carrier's loss cost, creating a self-reinforcing cycle where the platform's growth makes it more valuable to every participant. This is the same economic physics that drives Costco's flywheel — except Copart operates in a duopoly with 80-90% market concentration rather than competing against hundreds of retailers.</p><p>The moat trajectory is WIDENING, which in my framework matters more than current width. The 9% ASP growth excluding catastrophe effects — achieved while industry vehicle values normalized — is not just evidence of marketplace superiority; it is evidence that the superiority is accelerating. Each year, the buyer liquidity advantage compounds: more international buyers join the platform, AI-driven matching improves price discovery, and the growing asymmetry between Copart's auction outcomes and IAA's makes switching increasingly irrational for insurance carriers. This is a business where execution is building the moat, not coasting on legacy advantage — precisely the pattern I identified in Carvana before the market recognized its competitive position.</p><p>The industry is definitively STATIC — no technological disruption can disintermediate the physical handling of wrecked vehicles — which means moat width matters enormously and the risk of complacency is low. At $33.39, my estimated forward return of 11-13% falls short of my 15% hurdle rate. I would begin accumulating at $28-30 where the math clears my threshold, and this would become a core 5-7% position in my portfolio. The founder-led culture (Johnson family continuing involvement) passes my sledgehammer test — these are people who built the business over decades and treat it as their life's work.

Key Points

  • Copart's reinvestment runway is the most underappreciated aspect of this business. The company is in the middle innings of a global expansion — salvage auction markets in continental Europe, the Middle East, and Asia are fragmented and underdeveloped compared to the US. Each new market requires upfront investment in land, technology, and buyer network development, but the long-term returns on these investments should approach or exceed US-level ROIC as the platforms mature and achieve scale. This is a genuine multi-decade compounding opportunity.
  • The company's decision to own rather than lease land is strategically brilliant from a reinvestment perspective. While it depresses near-term FCF (capex is elevated), it creates a permanent competitive advantage — new entrants cannot simply lease their way into the business because the land required for salvage operations is increasingly scarce near urban centers. Copart is essentially building a land bank that appreciates while generating high-return operating income. The elevated capex is an investment, not a cost, and should normalize as the current build cycle completes.
  • The ROIC of 16.21% (TTM) is solid but understates the economics of the core business because it includes the drag from the heavy land investment cycle and the cash drag from the $2B+ cash position sitting on the balance sheet. Adjusting for excess cash and normalizing capex, the core business ROIC is likely in the 20-25% range, which places Copart among the highest-quality reinvestment opportunities in public markets.

Pushback & Concerns

  • I push back on Dev Kantesaria's emphasis on FCF-after-SBC as the primary metric. While I agree SBC dilution is a concern, Copart's SBC is modest relative to technology companies and serves a legitimate purpose in retaining operational talent across a geographically dispersed land-based business. The incremental dilution of approximately 0.7% per year (before buybacks) is manageable and should not be the primary lens through which we evaluate a business with 10%+ earnings growth potential.
Mohnish Pabrai Initiate a 4-5% portfolio position at current prices. This is a business I would be comfortable owning for 10+ years through any cycle, and the current price offers reasonable entry into a franchise that rarely trades at a cyclical-trough multiple.
Interesting business. I acknowledge the moat is genuine — this is a duopoly with network effects, physical infrastructure barriers, and secular tailwinds that I find qualitatively compelling. If I saw this business trading at 10-12x earnings during a severe insurance cycle trough — perhaps at $14-17 per share — I would be very interested. At that level, the asymmetry shifts dramatically: downside of 20-30% versus upside of 200-300% on a volume recovery and multiple re-rating. That is the kind of setup I look for.</p><p>But at $33.39 and 21x trailing earnings, this fails my hard valuation gates. I cannot achieve 3:1 upside/downside from this starting point — the stock would need to reach $100 for a triple, which implies a market cap of $97 billion for a salvage vehicle auction company. While theoretically possible over a very long horizon, it is not the kind of mispriced bet that my framework is designed to capture. I would rather deploy capital into deeply discounted cyclicals where the math is more compelling.</p><p>I respect the council members who advocate buying near fair value for compounders — Kantesaria's 'never a bad time' philosophy has merit for his framework. But my framework is different: I need prices that imply the business is in distress when it is not, or that the cycle is permanently broken when it is temporarily impaired. Copart at $33.39 reflects neither condition.

Key Points

  • This is a classic Pabrai setup — a high-quality business facing a temporary, well-understood cyclical headwind that the market is pricing as if it might be permanent. Insurance volume cycles have a 100% historical reversion rate. Consumers who drop collision coverage or raise deductibles eventually reverse those decisions — often prompted by a single accident scare, a vehicle loan requirement, or simply the return of affordability as insurance rates stabilize. The question is when, not if, and at 23x TTM earnings, the market is paying me to be patient.
  • The 'tails I don't lose much' side of the equation is compelling. Copart owns its land (a scarce, appreciating asset), operates in a structural duopoly with 35-40% operating margins, generates approximately $960M in annual free cash flow even in a down cycle, and holds roughly $2B in net cash. In a severe downside scenario — say units decline another 10% and margins compress 300 basis points — FCF might drop to $700-750M, but the business remains solidly profitable and the balance sheet absorbs the stress with ease. The floor is approximately $27-28 per share, representing roughly 15-17% downside from here.
  • I am cloning the conviction of fundamental franchise analysis here. Copart's competitive position has strengthened through every cycle over the past 20 years. Market share has grown, international presence has expanded, and the technology platform has widened the gap versus IAA. Cyclical weakness in a franchise that gets structurally stronger through cycles is exactly the temporary problem I look for — it's the kind of situation where doing nothing (holding through the trough) generates excellent long-term returns.

Pushback & Concerns

  • I respectfully challenge Charlie Munger's skepticism about the land portfolio as a downside protector. While salvage yards are specialized assets, Copart's locations near major metropolitan areas have substantial alternative-use value for logistics, last-mile delivery, and industrial purposes. The land portfolio alone is likely worth $8-10 billion at replacement cost — roughly 25-30% of the current market cap. This is not a theoretical floor; it represents real, tangible asset value that limits permanent capital loss.
Pulak Prasad Set limit orders at $28 and exercise extreme patience. Copart has traded below $28 as recently as 2022, and continued insurance volume weakness could present another entry opportunity within 12-18 months.
Copart passes my evolutionary survival test with the highest marks I have assigned to any non-Indian business. The evidence is overwhelming: fifteen consecutive years of net income growth spanning the Great Financial Crisis recovery, the COVID pandemic (during which revenue declined only 8% and margins actually expanded), and the current insurance volume downturn. This is a business that has been stress-tested by the harshest economic environments in modern history and emerged stronger each time. In my framework, survival through multiple crises is the single most reliable predictor of long-term investment success, because it demonstrates that the business model is genuinely adapted to its environment rather than merely benefiting from favorable conditions.</p><p>The slow-changing nature of the salvage auction industry is precisely what my framework rewards. Vehicle complexity trends change over decades, not quarters. Insurance carrier relationships are measured in years, not months. And the physical infrastructure — storage yards near population centers — is a permanent asset that appreciates rather than depreciates. This stands in sharp contrast to the fast-changing technology industries I avoid, where competitive advantages can evaporate in a single product cycle. Copart's key value drivers are remarkably few and remarkably stable: buyer liquidity, yard capacity, towing network density, and insurance carrier relationships. I can monitor these four variables over the next decade with high confidence.</p><p>I focus obsessively on avoiding big risks, and the risk assessment here is favorable. The insurance volume cycle is a moderate risk that is clearly cyclical (historical pattern well-established). The capital allocation concern is real but correctable (buyback program initiated). There is no existential risk from technology disruption, no leverage risk from debt, and no key-man risk given the institutional depth of the organization. At $28-30, this becomes a core holding that I would expect to own for a decade or longer.

Key Points

  • Copart exhibits the hallmarks of a Darwinian survivor — a business that has not merely endured competition and cycles but has emerged stronger from every challenge. Over the past two decades, the company has survived the transition from physical to online auctions (which it led), weathered the 2008-09 financial crisis, navigated the rise and eventual acquisition of its primary competitor's parent, and maintained market share dominance through continuous technology and land infrastructure investment. Businesses that survive this many evolutionary pressures develop organizational capabilities that compound over decades.
  • The duopoly market structure is itself a product of Darwinian selection — dozens of regional salvage auction companies have been absorbed or eliminated over the past 30 years, leaving only Copart and IAA with the scale, network effects, and land infrastructure to serve national insurance carriers. This natural selection process has created barriers to entry that are nearly impossible to replicate. A new entrant would need to simultaneously assemble a global buyer network, acquire hundreds of land parcels near major cities, build technology platforms, and establish carrier relationships — a multi-billion-dollar, multi-decade undertaking with no guarantee of success.
  • My primary concern is the long-tail existential risk from autonomous driving and advanced driver assistance systems. If accident frequency declines structurally by 30-50% over the next 15-20 years, Copart's total addressable market contracts proportionally. While this timeline is long, evolutionary investors must think in decades, and I cannot ignore a plausible scenario where the company's core demand driver — vehicle accidents — diminishes materially. This risk warrants a wider margin of safety than other council members require, which is why I insist on entry below $28.

Pushback & Concerns

  • I push back on David Tepper and Mohnish Pabrai's willingness to buy at current prices without demanding greater compensation for tail risks. The insurance volume cycle will indeed normalize, but my concern extends beyond the current cycle to structural questions about accident frequency in an ADAS/autonomous driving future. At $33.39, the stock prices in cyclical recovery but provides minimal cushion against longer-term technological disruption. Paying $28 instead of $33 buys roughly 15% additional margin of safety — meaningful insurance against risks that are difficult to quantify but impossible to dismiss.